Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products
JAMA · 2024
DOI: 10.1001/jama.2024.6834 ↗Kurz gefasst
Fallbericht in der Zeitschrift JAMA, 2024. Verfasst von Robert P Dickson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Washtenaw County Tuberculosis Program, Ypsilanti, Michigan. Hauptthemen laut MEDLINE: Government Regulation, United States Food and Drug Administration, Bone Transplantation, Bone and Bones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint discusses the death of a patient caused by unregulated biological products and efforts to encourage federal government oversight of such products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Washtenaw County Tuberculosis Program, Ypsilanti, Michigan.
- University of Michigan Medical School, Ann Arbor.
- US House of Representatives, Washington, DC.
Zitieren
APA
Dickson, R. P., & Dingell, D. A. (2024). Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products. JAMA. https://doi.org/10.1001/jama.2024.6834
Vancouver
Dickson RP, Dingell DA. Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products. JAMA. 2024. doi:10.1001/jama.2024.6834
BibTeX
@article{Dickson2024,
author = {Dickson, Robert P and Dingell, Deborah A},
title = {Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue–Based Products},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.6834}
}
EUVIMED